30% of Diabetes Patients Admit Skipping Insulin Injections
Patricia DeCock, Medical Affairs Manager Diabetes at Sanofi Aventis, joins Pharma IQ to discuss the problems associated with patient adherence to treatment of Type 1 and 2 diabetes, in paediatrics, adolescents and adults. In this exclusive interview, DeCock outlines the origins and remedies of each diabetes type, the development of hypoglycaemia, psychological impact on diabetes sufferers and the ramifications for treatment compliance.
To continue reading this story
Please note: That all fields marked with an asterisk (*) are required.